Emerging evidences have reported that NEDD4L may function as a tumor suppressor that is frequently reduced in human carcinomas of pancreatic [37], colorectal [35], melanoma [36], ovarian [38] and lung [25, 26]. This evidence concerns the gene NEDD4L and exocrine pancreatic carcinoma.